TY - JOUR
T1 - Mesenchymal stem cell contact promotes CCN1 splicing and transcription in myeloma cells
AU - Dotterweich, Julia
AU - Ebert, Regina
AU - Kraus, Sabrina
AU - Tower, Robert J.
AU - Jakob, Franz
AU - Schütze, Norbert
N1 - Funding Information:
This work was funded by The German Research Foundation within the Clinical Research Group-1586 SKELMET and the University of Wuerzburg in the funding programme Open Access Publishing. We thank Dr. Kurt Bommert for providing the INA-6 cell line, the orthopedic surgeons who supplied us with human femoral heads, Beate Geyer, Jutta Schneidereit, Jutta Meissner-Weigl, Sabine Zeck, and Susanne Wiesner for technical assistance, Viola Zehe for the preparation of MSC, and Dr. Alexander Keller for statistical assistance.
PY - 2014/6/25
Y1 - 2014/6/25
N2 - CCN family member 1 (CCN1), also known as cysteine-rich angiogenic inducer 61 (CYR61), belongs to the extracellular matrix-associated CCN protein family. The diverse functions of these proteins include regulation of cell migration, adhesion, proliferation, differentiation and survival/apoptosis, induction of angiogenesis and cellular senescence. Their functions are partly overlapping, largely non-redundant, cell-type specific, and depend on the local microenvironment. To elucidate the role of CCN1 in the crosstalk between stromal cells and myeloma cells, we performed co-culture experiments with primary mesenchymal stem cells (MSC) and the interleukin-6 (IL-6)-dependent myeloma cell line INA-6. Here we show that INA-6 cells display increased transcription and induction of splicing of intron-retaining CCN1 pre-mRNA when cultured in contact with MSC. Protein analyses confirmed that INA-6 cells co-cultured with MSC show increased levels of CCN1 protein consistent with the existence of a pre-mature stop codon in intron 1 that abolishes translation of unspliced mRNA. Addition of recombinant CCN1-Fc protein to INA-6 cells was also found to induce splicing of CCN1 pre-mRNA in a concentration-dependent manner. Only full length CCN1-Fc was able to induce mRNA splicing of all introns, whereas truncated recombinant isoforms lacking domain 4 failed to induce intron splicing. Blocking RGD-dependent integrins on INA-6 cells resulted in an inhibition of these splicing events. These findings expand knowledge on splicing of the proangiogenic, matricellular factor CCN1 in the tumor microenvironment. We propose that contact with MSC-derived CCN1 leads to splicing and enhanced transcription of CCN1 which further contributes to the translation of angiogenic factor CCN1 in myeloma cells, supporting tumor viability and myeloma bone disease.
AB - CCN family member 1 (CCN1), also known as cysteine-rich angiogenic inducer 61 (CYR61), belongs to the extracellular matrix-associated CCN protein family. The diverse functions of these proteins include regulation of cell migration, adhesion, proliferation, differentiation and survival/apoptosis, induction of angiogenesis and cellular senescence. Their functions are partly overlapping, largely non-redundant, cell-type specific, and depend on the local microenvironment. To elucidate the role of CCN1 in the crosstalk between stromal cells and myeloma cells, we performed co-culture experiments with primary mesenchymal stem cells (MSC) and the interleukin-6 (IL-6)-dependent myeloma cell line INA-6. Here we show that INA-6 cells display increased transcription and induction of splicing of intron-retaining CCN1 pre-mRNA when cultured in contact with MSC. Protein analyses confirmed that INA-6 cells co-cultured with MSC show increased levels of CCN1 protein consistent with the existence of a pre-mature stop codon in intron 1 that abolishes translation of unspliced mRNA. Addition of recombinant CCN1-Fc protein to INA-6 cells was also found to induce splicing of CCN1 pre-mRNA in a concentration-dependent manner. Only full length CCN1-Fc was able to induce mRNA splicing of all introns, whereas truncated recombinant isoforms lacking domain 4 failed to induce intron splicing. Blocking RGD-dependent integrins on INA-6 cells resulted in an inhibition of these splicing events. These findings expand knowledge on splicing of the proangiogenic, matricellular factor CCN1 in the tumor microenvironment. We propose that contact with MSC-derived CCN1 leads to splicing and enhanced transcription of CCN1 which further contributes to the translation of angiogenic factor CCN1 in myeloma cells, supporting tumor viability and myeloma bone disease.
KW - CCN1
KW - Mesenchymal stem cells
KW - Multiple myeloma
KW - Splicing
UR - http://www.scopus.com/inward/record.url?scp=84902946339&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84902946339&partnerID=8YFLogxK
U2 - 10.1186/1478-811X-12-36
DO - 10.1186/1478-811X-12-36
M3 - Article
C2 - 24965524
AN - SCOPUS:84902946339
SN - 1478-811X
VL - 12
JO - Cell Communication and Signaling
JF - Cell Communication and Signaling
IS - 1
M1 - 36
ER -